colchicine has been researched along with Bile Duct Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chuang, WL; Kuoc, CH; Lin, ZY; Wu, CC | 1 |
Broomé, U; Danielsson, A; Hultcrantz, R; Järnerot, G; Lööf, L; Olsson, R; Ryden, BO; Wahren, B | 1 |
1 trial(s) available for colchicine and Bile Duct Cancer
Article | Year |
---|---|
A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
Topics: Adult; Antigens, Tumor-Associated, Carbohydrate; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Cholangiocarcinoma; Cholangitis, Sclerosing; Colchicine; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Risk Factors; Time Factors | 1999 |
1 other study(ies) available for colchicine and Bile Duct Cancer
Article | Year |
---|---|
Clinically acceptable colchicine concentrations have potential for the palliative treatment of human cholangiocarcinoma.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Bile Duct Neoplasms; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Colchicine; Electron Transport Complex IV; Humans; Mice; Mice, Nude | 2015 |